DISORDERS/DIFFERENCES OF SEX DEVELOPMENT: TERTIARY CENTRE EXPERIENCE

  • Snjezana Mijatovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia
  • Tatjana Milenkovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia;
  • Katarina Sedlecki Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia;
  • Vladimir Kojovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia; School of Medicine, University of Belgrade, Belgrade, Republic of Serbia
  • Predrag Ilic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia; School of Medicine, University of Belgrade, Belgrade, Republic of Serbia
  • Jelena Martic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia; School of Medicine, University of Belgrade, Belgrade, Republic of Serbia
  • Katarina Mitrovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia; School of Medicine, University of Belgrade, Belgrade, Republic of Serbia
  • Sladjana Todorovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia
  • Marko Marjanovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia
  • Jovana Toncev Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia
  • Sanja Panic-Zaric Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia
  • Rade Vukovic Mother and Child Health Care Institute of Serbia „Dr Vukan Čupić”, Belgrade, Republic of Serbia; School of Medicine, University of Belgrade, Belgrade, Republic of Serbia https://orcid.org/0000-0002-1592-4105
DOI: https://doi.org/10.5937/zdravzast50-33283
Keywords: disorders of sex development, differences of sex development, congenital adrenal hyperplasia, gonadal dysgenesis, androgen insensitivity syndrome

Abstract


Introduction/aim: Disorders of sex development (DSD) comprise a heterogeneous group of congenital conditions with a difference between chromosomal, gonadal sex and the appearance of the external genitalia. The frequency of DSD is 1: 4500-5500 newborns per year. Congenital adrenal hyperplasia (CAH) due to the deficiency of the 21-hydroxylase enzyme is one of the most common and best-known causes of DSD. Other forms of CAH, as well as other causes of DSD, occur with significantly lower individual frequencies and are thus more challenging to diagnose and treat. The aim of the study was to analyse the etiology and clinical characteristics of DSD, as well as changes in the diagnostic and therapeutic approach to DSD in the tertiary center during the previous 13 years.
Methods: The study was conducted in the form of a retrospective cohort study which included all patients investigated for DSD at the Department of Endocrinology of Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic" during the period from December 2007 until November 2020. Children with DSD caused by CAH due to 21-hydroxylase deficiency were not included in this study. 
Results: The study included a total of 31 children with DSD: 24 children (77%) had 46XY DSD, 3 (10%) had 46XX DSD, and 4 children (13%) had chromosomal DSD. A definitive diagnosis of specific etiology has been made in 25 children (81%), and the most common etiology of DSD was gonadal dysgenesis (55%), followed by the androgen insensitivity syndrome (10%) and atypical forms of CAH (7%). During the period 2 (2016-2020) more children with DSD (n = 18) were examined compared to the period 1 (2007-2015) and the specific etiological diagnosis was established in a larger number of children with DSD (89%) compared to the period 1 (69%). Also, during period 2 (2016-2020) genital surgery was performed in a significantly lesser number of children (11%) and at a later age (average age 6.8 years) than in period 1 (64%, average age 4.8 years; p <0.05).
Conclusion: During the latter period (2016-2020), there has been an increase in the number of investigated children as well as the percentage of DSD with established specific etiology. Also, the diagnosis is increasingly being made on the basis of genetic analysis, and genitoplasty is performed in a decreasing number of children and at a later age. A holistic and multidisciplinary approach is required for the evaluation treatment of children with DSD.

References

Thyen U, Lanz K, Paul-Martin Holterhus PM, Hiort O. Epidemiology and Initial Management of Ambiguous Genitalia at Birth in Germany. Horm Res 2006; 66(4):195-203.

Lee PA, Nordenström A, P Houk CP, S Ahmed SF, Auchus R, Baratz A, et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approachand Care. Horm Res Paediatr 2016; 85(3):158-80.

Kumar J, Kumar V, Bhatia V, Preeti Dabadghao P, Chaturvedi S, Kapoor R et al. Managing disorder of sexual development surgically: A single center experience. Indian J Urol 2012; 28(3):286-91.

Kim KS, Kim J. Disorder of sex development. Korean J Urol 2012; 53(1):1-8.

Man E, GOSH DSD MDT, Achermann J. A single centre experience of differences/disorders in sex development over 20 years. Endocrine Abstracts 2016; 45 OC6.9.

Ahmed SF, Achermann JC, Arlt W, Balen A, Gerry Conway G, Edwards Z et al. Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clinical Endocrinol (Oxf) 2016; 84(5):771-88.

Van der Straaten S, Springer A, Zecic A, Hebenstreit D, Tonnhofer U, Gawlik A et al. The External Genitalia Score (EGS): A European Multicenter Validation Study. J Clin Endocrinol Metab 2020; 105(3): dgz142.

García-Acero M, Moreno-Niño O, Suárez-Obando F, Molina M, Manotas MC, Prieto JC et al. Disorders of sex development: Genetic characterization of a patient cohort. Mol Med Rep 2020; 21(1):97-106.

Hiort O, Birnbaum W, Marshall L, Wünsch L, Werner R, Schröder T, et al. Management of disorders of sex development. Nature reviews: endocrinology 2014; 10(9):520-9.

Selma Feldman Witchel. Disorders of Sex Development. Best practice and researcs. Clinical obstetrics and gynaecology 2018; 48:90-102.

Michelle M Ernst, Lih-Mei Liao, Arlene B. Baratz and David E. Sandberg. Disorders of Sex Development/Intersex: Gaps in Psychosocial Care for Children. Pediatrics 2018;142(2): e20174045.

Lisboa Gomes N, Tarini Chetty, Anne Jorgensen, Rod T Mitchell. Disorders of Sex Development-Novel Regulators, Impacts on Fertility, and Options for Fertility Preservation. Int J Mol Sci 2020; 21(7):2282.

Poyrazoglu S, Darendeliler F, Faisal Ahmed S, Hughes I, Bryce J, Jiang J et al. Birth weight in different etiologies of disorders of sex development. J Clin Endocrinol Metab 2017; 102(3):1044-1050.

Audi L, Ahmed SF, Krone N, Cools M, McElreavey K, Holterhus PM et al. Genetics in endocrinology: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocrinol 2018; 179(4): R197-R206.

Anu Bashamboo A, Ken Mc Elreavey K. Mechanism of sex determination in humans: Insights from disorders of sex development. Sex Dev 2016; 10(5-6):313-325.

American Academy of Pediatrics. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. Pediatrics 1996; 97:590-4.

Cools M, Nordenström A, Robeva R , Hall J , Westerveld P , Flück C et al. Caring for individuals with a difference of sex development (DSD): a Consensus Statement. Nat Rev Endocrinol 2018;14(7):415-429.

Acién P, Acién M. Disorders of Sex Development: Classification, Review,and Impact on Fertility. J Clin Med 2020; 9(11):3555.

Published
2021/10/15
Issue
Vol. 50 No. 3 (2021): Health Care
Section
ORIGINAL ARTICLE